Authors: PODUSLO JF WENGENACK TM CURRAN GL

Citation: Jf. Poduslo et al., THERAPEUTIC STRATEGIES FOR THE NONINVASIVE TREATMENT OF NEURODEGENERATIVE DISEASES BY POLYAMINE-MODIFIED NEUROTROPHIC FACTORS AND ANTIOXIDANT ENZYMES WITH INCREASED PERMEABILITY AT THE BLOOD-BRAIN-BARRIER AND RETAINED BIOACTIVITY, Protein engineering, 10, 1997, pp. 89-89

Authors: WENGENACK TM CURRAN GL OLSON EE PODUSLO JF

Citation: Tm. Wengenack et al., PUTRESCINE-MODIFIED CATALASE WITH PRESERVED ENZYMATIC-ACTIVITY EXHIBITS INCREASED PERMEABILITY AT THE BLOOD-NERVE AND BLOOD-BRAIN BARRIERS, Brain research, 767(1), 1997, pp. 128-135

Authors: WENGENACK TM CURRAN GL PODUSLO JF

Citation: Tm. Wengenack et al., POSTISCHEMIC, SYSTEMIC ADMINISTRATION OF POLYAMINE-MODIFIED SUPEROXIDE-DISMUTASE REDUCES HIPPOCAMPAL CA1 NEURODEGENERATION IN RAT GLOBAL CEREBRAL-ISCHEMIA, Brain research, 754(1-2), 1997, pp. 46-54

Authors: SLEMMON JR WENGENACK TM FLOOD DG

Citation: Jr. Slemmon et al., PROFILING OF ENDOGENOUS PEPTIDES AS A TOOL FOR STUDYING DEVELOPMENT AND NEUROLOGICAL DISEASE, Biopolymers, 43(2), 1997, pp. 157-170

Authors: SLEMMON JR MORGAN JI FULLERTON SM DANHO W HILBUSH BS WENGENACK TM

Citation: Jr. Slemmon et al., CAMSTATINS ARE PEPTIDE ANTAGONISTS OF CALMODULIN BASED UPON A CONSERVED STRUCTURAL MOTIF IN PEP-19, NEUROGRANIN, AND NEUROMODULIN, The Journal of biological chemistry, 271(27), 1996, pp. 15911-15917

Authors: WENGENACK TM BOLANOWSKI SJ

Citation: Tm. Wengenack et Sj. Bolanowski, QUANTITATIVE CLASSIFICATION OF UNITS IN V1 OF THE AWAKE MACAQUE RESPONDING TO DIFFUSE ILLUMINATION, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1216-1216